DIN 02552566 — ZORYVE 0.3 %
ZORYVE is a foam of Roflumilast (Topical) marketed by ARCUTIS CANADA, INC.. The full Roflumilast (Topical) monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02552566
- Brand name
- ZORYVE
- Active ingredient
- Roflumilast (Topical)
- Strength
- 0.3 %
- Dosage form
- FOAM
- Route
- TOPICAL
- Manufacturer
- ARCUTIS CANADA, INC.
- Health Canada status
- MARKETED
- Drug class
- Topical phosphodiesterase-4 (PDE4) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Roflumilast (Topical) products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02570793 | ZORYVE | 0.05 % | CREAM | ARCUTIS CANADA, INC. | MARKETED |
| 02556146 | ZORYVE | 0.15 % | CREAM | ARCUTIS CANADA, INC. | MARKETED |
| 02537532 | ZORYVE | 0.3 % | CREAM | ARCUTIS CANADA, INC. | MARKETED |